Benitec Biopharma Ltd ADR (BNTC) is a Healthcare · Biotechnology company listed on NASDAQ. Price $10.89 (-4.14%), Market cap $0.37B, 52-week low–high $10.06 ~ $16.56.
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, Califor
Financial statements, price targets, institutional (13F) holdings and related news for Benitec Biopharma Ltd ADR are updated in real time on BlackAll Trade.
Benitec Biopharma Ltd ADR trades at $10.89 (-4.14%). Real-time quotes and charts are available on BlackAll Trade.
Benitec Biopharma Ltd ADR has a market cap of about $0.37B.
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA int